Treatment outcomes of mild to moderate <i>Clostridioides difficile</i> infection in inflammatory bowel disease: an <scp>Australian</scp> experience
Metronidazole compared to vancomycin for treatment of mild to moderate CDI in IBD is effective however may be associated with higher rates of treatment failure.
Authors
- Astrid‐Jane Williams (ORCID: https://orcid.org/0000-0002-1756-5329)
- Watson Ng (ORCID: https://orcid.org/0000-0001-5424-6266)
- Susan J. Connor (ORCID: https://orcid.org/0000-0001-5606-0270)
- V. Chu (ORCID: https://orcid.org/0000-0002-5306-4409)
- Rachael Jacob (ORCID: https://orcid.org/0000-0002-7195-3154)
Institutions
- Liverpool Hospital (AU)
- UNSW Sydney (AU)
- Ingham Institute (AU)
- South Western Sydney Local Health District (AU)
Publication Details
- Journal
- Internal Medicine Journal
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1111/imj.16545
- Citations
- 1
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.39